- Home
- KPTI vs OWLT Comparison
KPTI vs OWLT Comparison
Compare KPTI & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPTI
- OWLT
- Stock Information
- Founded
- KPTI 2008
- OWLT 2013
- Country
- KPTI United States
- OWLT United States
- Employees
- KPTI N/A
- OWLT N/A
- Industry
- KPTI Biotechnology: Pharmaceutical Preparations
- OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KPTI Health Care
- OWLT Health Care
- Exchange
- KPTI Nasdaq
- OWLT Nasdaq
- Market Cap
- KPTI 90.7M
- OWLT 73.9M
- IPO Year
- KPTI 2013
- OWLT N/A
- Fundamental
- Price
- KPTI $0.62
- OWLT $4.69
- Analyst Decision
- KPTI Strong Buy
- OWLT
- Analyst Count
- KPTI 4
- OWLT 0
- Target Price
- KPTI $5.00
- OWLT N/A
- AVG Volume (30 Days)
- KPTI 676.1K
- OWLT 31.1K
- Earning Date
- KPTI 02-27-2025
- OWLT 03-06-2025
- Dividend Yield
- KPTI N/A
- OWLT N/A
- EPS Growth
- KPTI N/A
- OWLT N/A
- EPS
- KPTI N/A
- OWLT N/A
- Revenue
- KPTI $148,442,000.00
- OWLT $78,575,000.00
- Revenue This Year
- KPTI $5.47
- OWLT $40.64
- Revenue Next Year
- KPTI $6.33
- OWLT $20.09
- P/E Ratio
- KPTI N/A
- OWLT N/A
- Revenue Growth
- KPTI 1.77
- OWLT 74.76
- 52 Week Low
- KPTI $0.58
- OWLT $3.20
- 52 Week High
- KPTI $1.95
- OWLT $6.25
- Technical
- Relative Strength Index (RSI)
- KPTI 40.06
- OWLT 55.83
- Support Level
- KPTI $0.65
- OWLT $4.36
- Resistance Level
- KPTI $0.70
- OWLT $4.65
- Average True Range (ATR)
- KPTI 0.05
- OWLT 0.17
- MACD
- KPTI -0.00
- OWLT 0.03
- Stochastic Oscillator
- KPTI 11.00
- OWLT 89.80
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
About OWLT Owlet Inc.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.